Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MIF | P14174 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.30 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29831 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL30793 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL8928218 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL2801674 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL31034 | 1.00 | — | — | |
| SCHEMBL30759 | 1.00 | — | — | |
| SCHEMBL2795953 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL386178 | 1.00 | LMNA (0.40) | LMNAMEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL30599 | 0.97 | — | — | |
| SCHEMBL16595111 | 0.91 | GAA (0.47) | LMNAMEN1KMT2ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507612-B2 | Aziridine crosslinking agents for acrylic adhesives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-08-13 | — | — | US | disclosed |
| EP-2406338-B1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES CO (US) | 2012-11-28 | — | — | EP | disclosed |
| EP-2406338-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M Innovative Properties Company (US) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010104645-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-09-16 | — | — | WO | disclosed |
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-09-09 | — | — | US | disclosed |
| EP-0968074-B1 | THERMOPLASTIC LENS BLOCKING MATERIAL | MINNESOTA MINING & MFG (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-0851800-B1 | THERMOPLASTIC LENS BLOCKING MATERIAL | MINNESOTA MINING & MFG (US) | 2002-06-05 | — | — | EP | disclosed |
| US-6126528-A | Preformed ophthalmic lens base block with textured surface | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-10-03 | — | — | US | disclosed |
| US-6107366-A | A HOMO OR COPOLYMER OF EPSILON-CAPROLACTONE AND A MODIFIER SELECTED FROM A CARBOXYLIC ACID, STRAIGHT OR BRANCHED CHAIN MONOHYDRIC ALCOHOL, POLYETHYLENE GLYCOL, AND ALKYL ALCOHOL MODIFIED POLYETHERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-08-22 | — | — | US | disclosed |
| EP-1009586-A1 | PREFORMED OPHTHALMIC LENS BASE BLOCK WITH TEXTURED SURFACE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-06-21 | — | — | EP | disclosed |
| US-5885700-A | SOLIDIFIED MASS OF LOW MELTING THERMOPLASTIC BLOCKING COMPOSITION COMPRISING A BLEND OF BETWEEN 30 AND 65 WEIGHT PERCENT OF A HYDROCARBON RESIN AND BETWEEN 20 AND 70 WEIGHT PERCENT OF A SIDE CHAIN CRYSTALLIZABLE HYDROCARBON POLYMER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-03-23 | — | — | US | disclosed |
| WO-1999011430-A1 | PREFORMED OPHTHALMIC LENS BASE BLOCK WITH TEXTURED SURFACE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5827390-A | HEATING THERMOPLASIC LENS BLOCKING COMPOSITION TO MELTING OR SOFTENING POINT, FORMING COMPOSITION INTO CAVITY AGAINST LENS BLANK, SOLIDIFICATION; NONTOXIC | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-10-27 | — | — | US | disclosed |
| WO-1998041359-A1 | THERMOPLASTIC LENS BLOCKING MATERIAL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-09-24 | — | — | WO | disclosed |
| EP-0851800-A1 | THERMOPLASTIC LENS BLOCKING MATERIAL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-07-08 | — | — | EP | disclosed |
| US-5763075-A | HAVING SUFFICIENTLY LOW MELTING OR SOFTENING POINT TO PREVENT DAMAGING LENS BLANK DURING PROCESSING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-06-09 | — | — | US | disclosed |
| US-5754269-A | COMPRISING SOLIDIFIED MASS OF HOMOPOLYMER OR COPOLYMER OF EPSILON-CAPROLACTONE, SELECTED MODIFIER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-05-19 | — | — | US | disclosed |
| WO-1997010924-A1 | THERMOPLASTIC LENS BLOCKING MATERIAL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-03-27 | — | — | WO | disclosed |
| US-4173506-A | Bonding method utilizing polyester adhesive exhibiting \"open time\ | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1979-11-06 | — | — | US | disclosed |
| US-4059715-A | Adhesive composition and sheet-like product formed therewith | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227969-A1 | AZIRIDINE CROSSLINKING AGENTS FOR ACRYLIC ADHESIVES | AAAS, ADGRF1, CDH1 | LMNA 1936/4885MEN1 858/4885KMT2A 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.